MYC, a master regulator of multiple cellular processes such as cell proliferation, apoptosis and differentiation, is one of the most commonly rearranged oncogenes in B-cell lymphoma [3]. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.